Immunotoxin-mediated conditional disruption of specific neurons in transgenic mice.
AUTOR(ES)
Kobayashi, K
RESUMO
We have developed a transgenic approach, termed immunotoxin-mediated cell targeting (IMCT), to ablate conditionally selective neurons in the brain with the cytotoxic activity of immunotoxins. Transgenic mice were created that express the human interleukin 2 receptor alpha subunit (IL-2R alpha) under the control of the dopamine beta-hydroxylase (DBH) gene promoter. The animals were treated intracerebroventricularly with a recombinant immunotoxin, anti-Tac(Fv)-PE40, which selectively kills animal cells bearing human IL-2R alpha. The immunotoxin caused a characteristic behavioral abnormality only in the transgenic mice. This was accompanied by a dramatic loss of DBH-containing neurons and a significant decrease in DBH activity and norepinephrine levels in various regions of the brain. IMCT should provide a general technique to create animal models of human neurodegenerative disorders by targeting neurons or other cell types.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=42652Documentos Relacionados
- Prevention of immunotoxin-mediated vascular leak syndrome in rats with retention of antitumor activity.
- A novel strategy for the negative selection in mouse embryonic stem cells operated with immunotoxin-mediated cell targeting.
- Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice.
- Migratory arrest of gonadotropin-releasing hormone neurons in transgenic mice.
- Efficient and specific ribozyme-mediated reduction of bovine alpha-lactalbumin expression in double transgenic mice.
